Stock Scorecard
Stock Summary for Novo Nordisk (NVO) - $105.27 as of 11/20/2024 8:30:54 PM EST
Total Score
15 out of 30
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for NVO
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NVO
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NVO
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for NVO
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for NVO (66 out of 90)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 7 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 5 |
Latest News for for NVO
Financial Details for NVO
Company Overview |
|
|---|---|
| Ticker | NVO |
| Company Name | Novo Nordisk |
| Country | USA |
| Description | Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 6/30/2024 |
| Next Earnings Date | 2/5/2025 |
Stock Price History |
|
| Last Day Price | 105.27 |
| Price 4 Years Ago | 32.96 |
| Last Day Price Updated | 11/20/2024 8:30:54 PM EST |
| Last Day Volume | 7,091,862 |
| Average Daily Volume | 5,361,153 |
| 52-Week High | 147.59 |
| 52-Week Low | 93.70 |
| Last Price to 52 Week Low | 12.35% |
Valuation Measures |
|
| Trailing PE | 34.03 |
| Industry PE | 22.60 |
| Sector PE | 40.32 |
| 5-Year Average PE | 36.38 |
| Free Cash Flow Ratio | 6.22 |
| Industry Free Cash Flow Ratio | 12.03 |
| Sector Free Cash Flow Ratio | 27.97 |
| Current Ratio Most Recent Quarter | 0.94 |
| Total Cash Per Share | 16.93 |
| Book Value Per Share Most Recent Quarter | 27.07 |
| Price to Book Ratio | 26.49 |
| Industry Price to Book Ratio | 5.31 |
| Sector Price to Book Ratio | 20.88 |
| Price to Sales Ratio Twelve Trailing Months | 1.65 |
| Industry Price to Sales Ratio Twelve Trailing Months | 11.82 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Analyst Buy Ratings | 5 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 3,368,780,000 |
| Market Capitalization | 354,631,470,600 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 8/16/2024 |
| Last Dividend Amount | 0.93 |
| Current Dividend Amount | 0.52 |
| Total Years Dividend Increasing | 4 |
| Trailing Annual Dividend Rate | 1.45 |
| Trailing Annual Dividend Yield | 1.37% |
| Forward Annual Dividend Rate | 1.65 |
| Forward Annual Dividend Yield | 1.56% |
| 5-Year Dividend Payments Count | 10 |
| 3-Year Average Dividend Yield | 1.16% |
| 5-Year Average Dividend Yield | 1.50% |
| 1-Year Dividend Growth Rate Percentage | 29.00% |
| 3-Year Dividend Growth Rate Percentage | 18.40% |
| 5-Year Dividend Growth Rate Percentage | 13.73% |
| All-Time Dividend Growth Rate Percentage | 18.10% |
| Dividend Payout Ratio | 48.39% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 22.40% |
| Annual Earnings Growth | 50.71% |
| Reported EPS 12 Trailing Months | 2.99 |
| Reported EPS Past Year | 2.39 |
| Reported EPS Prior Year | 2.74 |
| Net Income Twelve Trailing Months | 94,721,000,000 |
| Net Income Past Year | 83,683,000,000 |
| Net Income Prior Year | 55,525,000,000 |
| Quarterly Revenue Growth YOY | 21.40% |
| 5-Year Revenue Growth | 15.74% |
| Operating Margin Twelve Trailing Months | 0.47 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 57,018,000,000 |
| Total Cash Past Year | 14,392,000,000 |
| Total Cash Prior Year | 12,653,000,000 |
| Net Cash Position Most Recent Quarter | 5,410,000,000 |
| Net Cash Position Past Year | -1,584,000,000 |
| Long Term Debt Past Year | 15,976,000,000 |
| Long Term Debt Prior Year | 20,775,000,000 |
| Total Debt Most Recent Quarter | 51,608,000,000 |
| Equity to Debt Ratio Past Year | 0.87 |
| Equity to Debt Ratio Most Recent Quarter | 0.70 |
| Total Stockholder Equity Past Year | 106,561,000,000 |
| Total Stockholder Equity Prior Year | 83,486,000,000 |
| Total Stockholder Equity Most Recent Quarter | 120,522,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 67,031,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 19.90 |
| Free Cash Flow Past Year | 70,012,000,000 |
| Free Cash Flow Prior Year | 64,134,000,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -3.50 |
| MACD Signal | -3.58 |
| 20-Day Bollinger Lower Band | 103.73 |
| 20-Day Bollinger Middle Band | 125.96 |
| 20-Day Bollinger Upper Band | 148.19 |
| Beta | 0.16 |
| RSI | 35.89 |
| 50-Day SMA | 123.34 |
| 150-Day SMA | 85.78 |
| 200-Day SMA | 74.99 |
System |
|
| Modified | 11/19/2024 8:40:55 AM EST |